Colony Stimulating Factor and Interferon Mix
Bulk blend of CSF and IFN for enhancing immune response in chemotherapy patients. Fits 3002.14.00 as mixed immunological products (CSF, IFN) not put up for retail.
Import Duty Rates by Country of Origin
| Origin Country | MFN Rate | Ch.99 Surcharges | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇨🇦Canada | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If waste pharmaceuticals unfit for use
Expired or unfit products specifically under 3006(k).
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Document CSF/IFN blending process to prove mixed status
• FDA biologics license verification required pre-import
Related Products under HTS 3002.14.00
Mixed Interleukin and TNF Preparation
Combined IL and TNF modulators for rheumatoid arthritis therapy in bulk form. 3002.14.00 for mixed interleukins/TNF immunologicals.
Biotech Antibody and Chemokine Solution
Mixed MAB and chemokine solution for inflammation control. HTS 3002.14.00 applies.
Growth Factor and MAB Blend
Bulk GF-MAB mix for wound healing immunology.
Hematopoietin Antibody Cocktail
Mixed hematopoietin and antibody for blood disorders.
Mixed Monoclonal Antibody Cocktail for Cancer Therapy
A blended preparation of multiple monoclonal antibodies (MABs) such as trastuzumab and pertuzumab for targeted cancer immunotherapy. Classified under HTS 3002.14.00 as mixed immunological products not in measured doses or retail packaging, involving peptides and proteins regulating immunological processes.
Blended Interferon-Alpha and Interleukin-2 Preparation
A mixed solution of recombinant interferon-alpha (IFN-α) and interleukin-2 (IL-2) for immunotherapy in viral infections and cancer. Falls under HTS 3002.14.00 as mixed immunological products (interferons and interleukins) not prepared for retail sale or in measured doses.